Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Lassa Fever (Lassa Hemorrhagic Fever) - Overview
Lassa Fever (Lassa Hemorrhagic Fever) - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Lassa Fever (Lassa Hemorrhagic Fever) - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Lassa Fever (Lassa Hemorrhagic Fever) - Companies Involved in Therapeutics Development
Curevac NV
Emergent BioSolutions Inc
FUJIFILM Toyama Chemical Co Ltd
GeoVax Labs Inc
Globavir Biosciences Inc
Helix Biogen Institute
ImmunityBio Inc
Inovio Pharmaceuticals Inc
Kineta Inc
Themis Bioscience GmbH
Tonix Pharmaceuticals Holding Corp
Zalgen Labs LLC
Lassa Fever (Lassa Hemorrhagic Fever) - Drug Profiles
(Ebola + Lassa Fever + Marburg) vaccine - Drug Profile
Product Description
Mechanism Of Action
(Lassa fever + rabies) vaccine - Drug Profile
Product Description
Mechanism Of Action
arevirumab-3 - Drug Profile
Product Description
Mechanism Of Action
History of Events
favipiravir - Drug Profile
Product Description
Mechanism Of Action
History of Events
GBV-006 - Drug Profile
Product Description
Mechanism Of Action
History of Events
GEOLM-01 - Drug Profile
Product Description
Mechanism Of Action
History of Events
hemorrhagic fever vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
INO-4500 - Drug Profile
Product Description
Mechanism Of Action
History of Events
lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
Lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
lassa fever vaccine - Drug Profile
Product Description
Mechanism Of Action
lassa fever vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
lassa fever vaccine 2 - Drug Profile
Product Description
Mechanism Of Action
lassa vaccine - Drug Profile
Product Description
Mechanism Of Action
History of Events
LHF-535 - Drug Profile
Product Description
Mechanism Of Action
History of Events
ML-29 - Drug Profile
Product Description
Mechanism Of Action
Small Molecules for Lassa Fever - Drug Profile
Product Description
Mechanism Of Action
TNX-3500 - Drug Profile
Product Description
Mechanism Of Action
History of Events
Vaccine for Infectious Diseases and Oncology - Drug Profile
Product Description
Mechanism Of Action
History of Events
Lassa Fever (Lassa Hemorrhagic Fever) - Dormant Projects
Lassa Fever (Lassa Hemorrhagic Fever) - Product Development Milestones
Featured News & Press Releases
Oct 26, 2021: INOVIO completes enrollment of phase 1B clinical trial for its D vaccine candidate against Lassa fever, INO-4500, in West Africa
Jul 14, 2021: Batavia successfully uses innovative hip-vax to manufacture IAVI’s lassa fever vaccine candidate for phase I clinical trials
Jun 15, 2021: EDCTP and CEPI Funding moves IAVI’s lassa fever vaccine candidate into advanced clinical development
Feb 23, 2021: INOVIO announces first subject dosed in phase 1B clinical trial for its D vaccine against lassa fever, INO-4500, in West Africa
Mar 25, 2020: Kineta presents clinical study results of LHF-535 at the Intertiol Conference on Antiviral Research (ICAR)
Oct 30, 2019: Themis Bioscience and CEPI trial Lassa fever vaccine
Aug 06, 2019: Kineta Secures $1.8 Million Funding Boost from Wellcome Trust on Positive Phase 1a Clinical Study Results with LHF-535
Jul 16, 2019: GeoVax announces upcoming presentation of lassa fever vaccine data
Jul 15, 2019: Kineta secures NIAID grant worth up to $5.8M to evaluate LHF-535 in Areviruses
May 23, 2019: Inovio doses patients in Phase I trial of Lassa virus vaccine INO-4500
Dec 11, 2018: Batavia Biosciences Partners with IAVI to Advance Development of Vaccine Against Lassa Fever
Sep 26, 2018: GeoVax awarded $2.4 million from U.S. Department of Defense to advance Lassa Fever Vaccine
Sep 15, 2018: Advanced preclinical development and production of master seed virus of GEO-LM01, a novel MVA-VLP vaccine against Lassa Fever
Sep 05, 2018: Kineta initiates first-in-human clinical trial of LHF-535 a novel therapy for lassa fever
Aug 20, 2018: Emergent and Profectus receive CEPI contract for Lassa virus vaccine
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures

List of Figures
Number of Products under Development for Lassa Fever (Lassa Hemorrhagic Fever), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Number of Products by Targets, 2022
Number of Products by Stage and Targets, 2022
Number of Products by Stage and Mechanism of Actions, 2022
Number of Products by Routes of Administration, 2022
Number of Products by Stage and Routes of Administration, 2022
Number of Products by Molecule Types, 2022
Number of Products by Stage and Molecule Types, 2022

List of Tables

List of Tables
Number of Products under Development for Lassa Fever (Lassa Hemorrhagic Fever), 2022
Number of Products under Development by Companies, 2022
Number of Products under Development by Universities/Institutes, 2022
Products under Development by Companies, 2022
Products under Development by Universities/Institutes, 2022
Number of Products by Stage and Target, 2022
Number of Products by Stage and Mechanism of Action, 2022
Number of Products by Stage and Route of Administration, 2022
Number of Products by Stage and Molecule Type, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Curevac NV, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Emergent BioSolutions Inc, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by FUJIFILM Toyama Chemical Co Ltd, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by GeoVax Labs Inc, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Globavir Biosciences Inc, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Helix Biogen Institute, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by ImmunityBio Inc, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Inovio Pharmaceuticals Inc, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Kineta Inc, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Themis Bioscience GmbH, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Tonix Pharmaceuticals Holding Corp, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Pipeline by Zalgen Labs LLC, 2022
Lassa Fever (Lassa Hemorrhagic Fever) - Dormant Projects, 2022